
- Teacher: Christian Mosoni
- Teacher: Marco Ruella
This introductory MOOC provides a comprehensive overview of adoptive T-cell immunotherapy, with a particular focus on chimeric antigen receptor (CAR) T-cell therapy. Through twelve concise video lectures, learners will explore the biological principles underlying T-cell immunity, CAR design, manufacturing, mechanisms of action, clinical applications, treatment-related toxicities, and emerging next-generation cellular immunotherapies. The course is designed for students approaching cellular immunotherapy for the first time and provides the foundational knowledge required for the subsequent MOOCs in the series.
The course is organized into 12 modules, each consisting of a 10-minute video lecture, accompanying slides, and a short formative quiz designed to reinforce the concepts presented.
Module 1 – Introduction to Adoptive T-Cell Immunotherapy
Module 2 – T-Cell Biology for Immunotherapy
Module 3 – Structure and Design of CARs
Module 4 – CAR-T Manufacturing
Module 5 – Approved CAR-T Therapies
Module 6 – Mechanisms of CAR-T Function
Module 7 – Resistance to CAR-T Therapy
Module 8 – Toxicities of CAR-T Therapy
Module 9 – Gene Editing and Next-Generation CAR-T Cells
Module 10 – Beyond CAR-T Cells
Module 11 – CAR-T Cells in Solid Tumors
Module 12 – Future Directions in Cellular Immunotherapy
Each module includes:
- one video lecture (~10 minutes)
- downloadable slides
- a formative quiz (3–5 questions)
The course concludes with a comprehensive final assessment consisting of 12 integrative questions (one per module), different from those presented during the course.
Upon successful completion of this MOOC, the learner will be able to:
-
Describe the fundamental principles of adaptive immunity and T-cell biology in the context of cellular immunotherapy.
-
Identify the structural components of chimeric antigen receptors and explain their respective biological functions.
-
Illustrate the major steps involved in the manufacturing process of CAR-T cell products.
-
Differentiate currently approved CAR-T cell therapies according to their indications and target antigens.
-
Explain the cellular and molecular mechanisms responsible for CAR-T cell activation, expansion, persistence, and tumor elimination.
-
Recognize the principal mechanisms of resistance that limit the efficacy of CAR-T cell therapy.
-
Identify the major toxicities associated with CAR-T cell therapy and describe their biological basis.
-
Compare current and emerging cellular immunotherapy platforms, including next-generation engineered immune cells.
-
Discuss future directions in cellular immunotherapy, including gene editing, synthetic biology, and novel therapeutic strategies.
Quiz Assessment
No prior knowledge of CAR-T cell therapy is required.
Learners are expected to possess basic undergraduate-level knowledge of:
-
cell biology
-
molecular biology
-
immunology
This MOOC serves as the entry point to the series and is recommended before enrolling in:
-
Translational Innovations in CAR-T Cell Therapy
-
Clinical Advances and Transformative Programs in CAR-T Therapy
Marco Ruella
marco.ruella@unito.it
For technical issues:
edvancedeh@unito.it